Pfizer is expected to rebound in 2025 with growth stabilized and dividend growth to continue. Learn why PFE stock is a Buy.

Our group of small-cap banks performed well in 2024, returning 19%. Read more to see why we expect an increase in bank M&A ...

Bankruptcy filings by US private equity portfolio companies hit a record high in 2024, led by consumer discretionary & healthcare sectors, according to S&P Global Market Intelligence data.

Read here for an analysis of Quanterix's volatile journey post-IPO, facing losses, compliance issues, and backlash from their ...

Discover three top monthly dividend stocks offering stability, growth potential, and consistent payouts for income investors ...

Discover the investment potential of Oportun Financial (OPRT) with strong profitability projections, and a focus on growth ...

Is Palantir (PLTR) stock a buy or sale amid a series of share sales by ARK ETFs managed by famed hedge fund manager Cathie ...

Learn how to combat longevity risk and inflation erosion in retirement by implementing durable income investing strategies, ...

Current portfolio income is projected to grow 3.53% in 2024. A recent reduction in estimated growth is largely a time issue ...

Discover why Bank of America Corporation's Series L preferred shares are a smart investment choice with a 6% yield and low ...

Investors should consider buying GNK due to strong financials, promising guidance, and favorable market conditions in the dry ...

Walgreens Boots Alliance surged by >25% today, following strong Q1 2025 earnings and revenue outperformance. Click here to ...